Contineum, a startup born from a Roche buyout, files for IPO
BioPharma Drive: Drug Pricing
MARCH 17, 2024
The biotech, formed as a successor to a company Roche acquired in 2018, has two drugs in clinical testing for neurological and immune diseases.
Sun.Mar 17, 2024
195 
Keeping score: novel method might help differentiate 2 serious skin diseases
SCIENMAG: Medicine & Health
MARCH 17, 2024
Your skin becomes red and spots filled with pus appear, so you visit a dermatologist. When these symptoms spread to the skin throughout the body, it is difficult for the physician to distinguish whether it is generalized pustular psoriasis (GPP) or acute generalized exanthematous pustulosis (AGEP), as both have similar symptoms.
Join 15,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Coding Marvels: Navigating Dynamic Apex in Salesforce
Perficient: Drug Development
MARCH 17, 2024
Aloha Trailblazers! Today we are going to understand and learn more about dynamic apex. As per Salesforce Documentation , Dynamic Apex enables developers to create more flexible applications. In simpler terms dynamic apex allows you to create generic code that could be reused along with multiple sObjects.Thus reducing the overhead of creating the block of code multiple times for multiple objects.
Pharmaceutical companies with the most ‘New Chemical Entity’ drugs
Drug Patent Watch
MARCH 17, 2024
Five years of exclusivity is provided for drugs which do not contain active molecules that have appeared in previously-approved drugs.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
New tentative approval for Sandoz Inc drug rifaximin
Drug Patent Watch
MARCH 17, 2024
Rifaximin is the generic ingredient in one branded drug marketed by Salix Pharms and is included in one NDA. There are twenty-nine patents protecting this compound.
Let's personalize your content